Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 653 participants.
Also called NCT01296412
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 653 participants
- Sponsor
- Registry
-
NCT01296412
-
- Other papers using this trial's data
- Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01296412. Randomized; no masking; primary purpose treatment. Start 2011-03-11 (actual); primary completion 2012-02-29 (actual). Results posted on 2013-03-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- sitagliptin
- Intervention (Drug)
- liraglutide
- Intervention (Drug)
- glimepiride
- Intervention (Drug)
- metformin
- Lead sponsor
- Merck Sharp & Dohme LLC
Record details
- Record id
cardio:ct-nct01296412- Content hash
51c5fb1b8b01e8143f68f924915e2a7499a4582c93ee95f03b075c40aadb1765